Clinical Trial Management - software & AI news

Daily news on software, AI, and companies shaping clinical trial management.

Showing 118 results
Press release cover image

Nov 4, 2026

Cognixion Now Enrolling NIH-Funded Study of Wearable Brain-Computer Interface Communication Device for People with ALS

First of its kind, longitudinal clinical study comparing Cognixion's investigational Brain Computer Interface (BCI) with the Market leading eye-tracking communication devices people with ALS currently rely upon for daily communicationSANTA BARBARA, Calif., Nov. 4, 2026 /PRNewswire/ -- Cognixion Corporation today announced that it is now enrolling participants in the CHOICE study, a research study of a wearable brain–computer interface (BCI) communication device for people living with amyotrophic
Press release cover image

Nov 3, 2026

Signant Health Introduces Signant SignalSpace™, a Connected Environment for Clinical Trial Data and Workflows

SignalSpace brings product and trial data into one connected environment, where AI agents dramatically improve data access and analyses so that clinical teams can think and act differently on the signals they see.PHILADELPHIA, Nov. 3, 2026 /PRNewswire/ -- Signant Health, a leading provider of evidence generation solutions for clinical trials, today announced Signant SignalSpace™, a connected environment that brings Signant applications, study activity, support, workflows, data, and AI-guided int
Press release cover image

Nov 3, 2026

LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization

LIPSIA-STRATEGY evaluated whether revascularization guided by angiography-based FFR using CAAS vFFR (vessel Fractional Flow Reserve), delivers clinical outcomes comparable to guidance by pressure wire-based FFR.Conclusive trial results provide further randomized clinical evidence validating CAAS vFFR as a safe and effective alternative for wire-based physiology-guided revascularization.Results independently confirm the findings of FAST III, demonstrating comparable clinical outcomes while enabli
Press release cover image

Nov 2, 2026

EClinCloud Analysis of 1,715 FDA Inspection Citations: A Complete Trial Master File Is Not a Reconstructable Trial

Across six fiscal years of FDA BIMO inspection data, protocol-compliance, informed-consent and case-history obligations account for 46.2% of citation occurrences — in the company's reading, the clearest signal that inspection readiness should focus on whether the trial record can reconstruct what happened, not on how many documents were stored.NINGBO, China, Nov. 2, 2026 /PRNewswire/ -- EClinCloud, an AI technology company for clinical research that builds a unified clinical cloud platform and e
Press release cover image

Oct 31, 2026

Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial.

SHANGHAI, Oct. 31, 2026 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ( "Zhimeng Biopharma") announced today that its independently developed next-generation potassium channel opener, CB03-154, intended for the treatment of amyotrophic lateral sclerosis (ALS), has successfully completed patient enrollment in its pivotal Phase 2/3 clinical trial, in total enrolled 255 patients. This significant milestone marks the entry of the critical stage in the clinical development of CB03-154 for ALS in C
Press release cover image

Oct 29, 2026

Precision Neuroscience Expands Clinical Network Beyond the U.S. with First International Site in Abu Dhabi

NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Today Precision Neuroscience Corporation (Precision), a leader in minimally invasive brain–computer interface (BCI) technology, announced the first international expansion of its clinical research network. Precision has signed a two-year memorandum of understanding with Cleveland Clinic Abu Dhabi, with the support of the Department of Health – Abu Dhabi (DoH), to evaluate its Layer 7™ cortical interface in collaborative clinical research. The agreeme
Press release cover image

Oct 28, 2026

Suvoda helps patients stay in trials with more travel choice and control through expanded Greenphire Travel

Key TakeawaysRideshare access expanded for clinical trial participants—Lyft, Uber Health, and Bolt provide direct access to ground transportation and cut routine coordination work for sites.One app now covers the entire trial journey—participants can view travel itineraries, book eligible rides, and manage study appointments and payments through the Suvoda App.Travel support flexes to match trial complexity—sites can directly initiate routine travel requests or choose a fully managed Concierge m
Press release cover image

Oct 28, 2026

Appian and PSI CRO Form Strategic Partnership to Advance AI-driven Clinical Trial Operations

First joint project launches a broader platform strategy for process orchestration across the clinical trial lifecycle BERLIN, Oct. 28, 2026 /PRNewswire/ -- Appian (Nasdaq: APPN) and PSI CRO announced today the launch of their first joint AI-powered process orchestration solution. The new offering automates clinical trial site identification and selection across therapeutic areas, indications, and geographies.Continue Reading The live solution is the first step in a shared vision by PSI and
Press release cover image

Oct 27, 2026

BLUE CROSS BLUE SHIELD OF MASSACHUSETTS COLLABORATES WITH MEDZOWN TO IMPROVE CLINICAL TRIAL ACCESS FOR MEMBERS WITH COMPLEX MEDICAL CONDITIONS

BOSTON, Oct. 27, 2026 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts ("Blue Cross") today announced a collaboration with Medzown, a precision medicine management company, to improve access to clinical trials and advanced therapies for eligible members with cancer and other complex medical conditions.Why it mattersThis collaboration brings new treatment options to eligible members, giving them an opportunity to access promising therapies in clinical trials that are not yet available comm
A minimalist representation of a human silhouette with a data stream.

Oct 26, 2026

Boehringer, Microsoft team up to explore digital patient twins for clinical trials

Boehringer Ingelheim and Microsoft have initiated a partnership aimed at leveraging AI-driven digital patient twins to enhance the design of clinical trials.Digital patient twins serve as computational models that represent individual patients, utilizing clinical and relevant data to forecast disease progression and potential outcomes under various scenarios. This collaboration seeks to refine clinical trial processes through advanced modeling techniques, including disease-progression and predic
Press release cover image

Oct 23, 2026

Alebund Pharmaceuticals Announces Poster Presentation by Partner R1 Therapeutics of Global Phase IIb Multi-Regional Clinical Trial Design for AP306 at ASN Kidney Week 2026

SHANGHAI, Oct. 23, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that its partner, R1 Therapeutics, Inc. ("R1"), presented a trial-in-progress poster outlining the design of the ongoing global Phase IIb multi-regional clinical trial of AP306, a first-in-class oral pan-phosphate transporter inhibitor, in patients with hyperphosphatemia receiving maintenance hemodialysis (NCT06712
Press release cover image

Oct 23, 2026

Tidepool Awarded Breakthrough T1D Grant to Advance Next-Generation Automated Insulin Delivery Algorithm

“Unannounced Meals” Functionality Would Provide Significant Quality-of-Life Improvements for People Living with Type 1 DiabetesPALO ALTO, Calif.--(BUSINESS WIRE)--Tidepool, a non-profit leader advancing innovation in diabetes technology, today announced it has been awarded research funding from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, to support clinical evaluation of an investigational “unannounced meal” feature for Tidepool Loop. First clea